Browsing Tag
Bora Pharmaceuticals
2 posts
MacroGenics exits GMP manufacturing operations as Bora expands U.S. biologics footprint
MacroGenics’ $122.5 million Bora sale boosts MGNX cash flexibility while shifting GMP manufacturing to a CDMO model.
Bora Pharmaceuticals set to shake up rare disease treatment with Pyros Pharmaceuticals acquisition
Bora Pharmaceuticals Co., Ltd. is intensifying its presence in the rare disease treatment market by acquiring U.S.-based Pyros…